Coronavirus: NAFDAC approves Chloroquine for Clinical Trials


The National Agency for Food and Drug Administration and Control(NAFDAC) has announced the approval of Chloroquine for clinical trials as doctors battle to find a cure for COVID-19.

Director-General of the Agency, Mojisola Adeyeye said that the drug has not yet been cleared for use in treating the virus, but for trials.

“NAFDAC is not approving Chloroquine as a product that has can be used for Coronavirus because there is no submission to us for registration but because it is under clinical trials, NAFDAC approves medicines meant for clinical trials.

“Therefore the medicine is being approved just for the clinical trials,”.

She called on researchers that are interested in doing a clinical trial on Chloroquine to come forward by visiting approved centres.

Show More

Leave a Reply

Your email address will not be published.

Back to top button